When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OVID - Ovid closes gaboxadol commercialization deal in Europe
Ovid Therapeutics Inc.
Ovid Therapeutics (NASDAQ:OVID) inks an agreement with Italian drugmaker Angelini Pharma S.p.A. for the development, manufacture and commercialization of OV101 (gaboxadol) for the potential treatment of Angelman syndrome in the EU, Switzerland, Turkey, UK and Russia.
More news on: Ovid Therapeutics Inc., Healthcare stocks news, Stocks on the move,